These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26926716)

  • 1. [Association of influenza, influenza vaccination and cardiovascular risk].
    Jiang Y; Zhang Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Feb; 50(2):110-3. PubMed ID: 26926716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza vaccination and risk for cardiovascular events: a nationwide self-controlled case series study.
    Sen A; Bakken IJ; Govatsmark RES; Varmdal T; Bønaa KH; Mukamal KJ; Håberg SE; Janszky I
    BMC Cardiovasc Disord; 2021 Jan; 21(1):31. PubMed ID: 33435871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation Between Cardiovascular Protection and Influenza Vaccination.
    Ngwudike CJ; Villalobos A
    Curr Cardiol Rep; 2023 Jun; 25(6):571-576. PubMed ID: 37058200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influenza and cardiovascular diseases].
    Gorczyca-Michta I; Wożakowska-Kapłon B
    Kardiol Pol; 2010 Oct; 68(10):1168-71. PubMed ID: 20967719
    [No Abstract]   [Full Text] [Related]  

  • 5. Influenza and atherosclerosis: vaccination for cardiovascular disease prevention.
    Madjid M; Awan I; Ali M; Frazier L; Casscells W
    Expert Opin Biol Ther; 2005 Jan; 5(1):91-6. PubMed ID: 15709912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza vaccination and secondary prevention of cardiovascular disease among Taiwanese elders-A propensity score-matched follow-up study.
    Wu HH; Chang YY; Kuo SC; Chen YT
    PLoS One; 2019; 14(7):e0219172. PubMed ID: 31260487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of the Cochrane Review: Influenza Vaccines for Preventing Cardiovascular Disease. Cochrane Database Syst Rev. 2015;5:CD005050].
    Caldeira D; Costa J; Vaz-Carneiro A
    Acta Med Port; 2015; 28(4):424-6. PubMed ID: 26574975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza Vaccination for Cardiovascular Prevention: Further Insights from the IAMI Trial and an Updated Meta-analysis.
    Maniar YM; Al-Abdouh A; Michos ED
    Curr Cardiol Rep; 2022 Oct; 24(10):1327-1335. PubMed ID: 35876953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology.
    Davis MM; Taubert K; Benin AL; Brown DW; Mensah GA; Baddour LM; Dunbar S; Krumholz HM; ;
    Circulation; 2006 Oct; 114(14):1549-53. PubMed ID: 16982936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of influenza vaccination in patients with cardiovascular disease: An overview of systematic reviews.
    Rodrigues BS; Alves M; Duarte GS; Costa J; Pinto FJ; Caldeira D
    Trends Cardiovasc Med; 2021 Jul; 31(5):315-320. PubMed ID: 32535214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Influenza Vaccination in Cardiovascular Disease: Systematic Review and Meta-Analysis.
    Gupta R; Quy R; Lin M; Mahajan P; Malik A; Sood A; Sreenivasan J; Bandyopadhyay D; Goel A; Agrawal A; Vyas AV; Patel NC; Frishman WH; Aronow WS
    Cardiol Rev; 2024 Sep-Oct 01; 32(5):423-428. PubMed ID: 37158999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influenza vaccination and prognosis for patients with high cardiovascular risk].
    Dmitrieva OA; Mironova OI; Fomin VV
    Ter Arkh; 2021 Sep; 93(9):1100-1105. PubMed ID: 36286871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of Influenza Vaccine Uptake in Patients With Cardiovascular Disease and Strategies for Improvement.
    Bhugra P; Grandhi GR; Mszar R; Satish P; Singh R; Blaha M; Blankstein R; Virani SS; Cainzos-Achirica M; Nasir K
    J Am Heart Assoc; 2021 Aug; 10(15):e019671. PubMed ID: 34315229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influenza vaccination as secondary prevention for cardiovascular disease].
    Vollaard AM; Slok ENE; van Dijkman PRM; Dekkers OM; Groeneveld GH
    Ned Tijdschr Geneeskd; 2023 Oct; 167():. PubMed ID: 37823884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology.
    Davis MM; Taubert K; Benin AL; Brown DW; Mensah GA; Baddour LM; Dunbar S; Krumholz HM; ; ; ; ; ; ; ; ; ; ;
    J Am Coll Cardiol; 2006 Oct; 48(7):1498-502. PubMed ID: 17010820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotective effect of influenza and pneumococcal vaccination in patients with cardiovascular diseases.
    Ciszewski A
    Vaccine; 2018 Jan; 36(2):202-206. PubMed ID: 29221893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza Vaccination for the Prevention of Cardiovascular Disease.
    Raffoul M; Lin KW
    Am Fam Physician; 2016 Mar; 93(5):357-8. PubMed ID: 26926972
    [No Abstract]   [Full Text] [Related]  

  • 18. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
    Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cardiovascular manifestations of influenza: a systematic review.
    Estabragh ZR; Mamas MA
    Int J Cardiol; 2013 Sep; 167(6):2397-403. PubMed ID: 23474244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza vaccination and cardiovascular morbidity and mortality: analysis of 292,383 patients.
    Loomba RS; Aggarwal S; Shah PH; Arora RR
    J Cardiovasc Pharmacol Ther; 2012 Sep; 17(3):277-83. PubMed ID: 22172681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.